Biotricity to Report Second Quarter Fiscal 2023 Financial Results on Nov. 14 at 4:30 p.m. ET
REDWOOD CITY, Calif. /ACCESSWIRE/November 1, 2022/ Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostics and consumer healthcare technology company, today announced that it will host a conference call on Monday, November 14 2022 at 4:30 p.m. ET to discuss its financial results for the second quarter of fiscal 2023 and provide an update on its activities.
Financial Results Conference Call
Additional details are available in the Investor Relations section of the Company’s website: https://www.biotricity.com/investors/
For those interested who are unable to participate in the conference call, a replay of the call will be available until November 28, 2022 and can be accessed by dialing +1-844-512-2921 (toll-free in the United States) or +1-412-317-6671 (International) and entering the replay PIN: 8592059.
Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Physicians and patients trust Biotricity’s unrivaled standard for preventive and personal care, including diagnostic and post-diagnostic solutions for chronic disease. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com.
KCSA Strategic Communications
Valter Pinto or Jack Perkins
THE SOURCE: Biotricity, Inc.
See the source version on accesswire.com: